CLDX · US market

Celldex Therapeutics Inc

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$2.53bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E-8.41×
Latest-quarter run-rate P/E-8.60×
Trailing P/S16096.05×
Latest-quarter run-rate P/S28716.82×

Calculation inputs

Trailing earnings
-US$300.55m
Latest-quarter run-rate earnings
-US$294.01m
Latest fiscal-year earnings
-US$258.76m
Trailing revenue
US$157.00k
Latest-quarter run-rate revenue
US$88.00k
Latest fiscal-year revenue
US$1.55m

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

  • SSDZX · DWS Small Cap Growth Fund - Class R61.00% weight · Holdings dated 30 June 2026
  • IHSAX · The Hartford Small Company Fund Class A0.76% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • XBI · State Street SPDR S&P Biotech ETF0.74% weight · Holdings dated 21 August 2026
  • HISCX · Hartford Small Cap Growth HLS Fund Class IA0.64% weight · Holdings dated 30 June 2026
  • ORSIX · North Square Dynamic Small Cap Fund Class I0.62% weight · Holdings dated 31 May 2026
  • FSCRX · Fidelity Small Cap Discovery Fund0.61% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • FJACX · Fidelity Series Small Cap Discovery Fund0.60% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • HSLAX · Hartford Small Cap Growth Fund Class A0.59% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • GSATX · Goldman Sachs Small Cap Value Insights Fund Class A0.47% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • HGHAX · The Hartford Healthcare Fund Class A0.42% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.